Janku Filip
Insider CIK 1862930 · GLUE Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-06-30 | 2026-07-01 | 5,407 | — | $0 | 81,093 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-30 | 2026-07-01 | 5,407 | $24.50 | $132.5K | 60,612 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-06-30 | 2026-07-01 | 5,407 | $13.41 | $72.5K | 66,019 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-06-29 | 2026-06-30 | 6,000 | — | $0 | 60,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-29 | 2026-06-30 | 6,000 | $22.95 | $137.7K | 59,992 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-06-29 | 2026-06-30 | 6,000 | $7.56 | $45.4K | 65,992 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-06-24 | 2026-06-25 | 30,000 | — | $0 | 66,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-06-24 | 2026-06-25 | 30,000 | $7.56 | $226.8K | 89,992 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-24 | 2026-06-25 | 30,000 | $21.42 | $642.6K | 59,992 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-06-23 | 2026-06-25 | 6,000 | — | $0 | 96,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-06-23 | 2026-06-25 | 6,000 | $7.56 | $45.4K | 71,837 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-23 | 2026-06-25 | 11,845 | $20.22 | $239.5K | 59,992 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-02-23 | 2026-02-24 | 9,189 | $19.50 | $179.2K | 65,837 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-05 | 2026-01-05 | 3,155 | $15.17 | $47.9K | 75,026 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-01-02 | 2026-01-05 | 139,000 | — | $0 | 139,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2026-01-02 | 2026-01-05 | 31,000 | — | $0 | 78,181 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-01-02 | 2025-01-06 | 161,000 | — | $0 | 161,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2025-01-02 | 2025-01-06 | 36,000 | — | $0 | 45,189 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-09-13 | 2024-09-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-01-02 | 2024-01-04 | 121,000 | — | $0 | 121,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2023-01-03 | 2023-01-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-12-15 | 2022-12-19 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-10-31 | 2022-11-01 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-03-01 | 2022-03-02 | 86,500 | — | $0 | 86,500 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-06-23 | 2021-06-25 | 387,069 | — | $0 | 387,069 | SEC↗ |